Bacterial Infections  >>  ciprofloxacin (Q3939)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ciprofloxacin (Q3939) / Bayer, Novartis
NCT00670215: BAYQ3939, 1000 mg Tablet in Transrectal Needle Biopsies of the Prostate (TRNBP) - Infection Prophylaxis

Completed
3
497
US, Canada, Europe, RoW
Ciprofloxacin single dose, Ciprofloxacin triple dose
Bayer
Bacterial Infections
 
10/04
NCT01561794: A Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics/Pharmacodynamics of BAYQ3939 in Patients With Bacterial Pneumonia

Completed
3
44
Japan
Ciprofloxacin (Cipro, BAYQ3939)
Bayer
Pneumonia
03/15
03/15

Download Options